Mexico vs Oman: Cause of death, by non-communicable diseases, ages 15-59, female
Mexico
51.2%
in 2021
Oman
51.1%
in 2021
Mexico rank
129th
Oman rank
130th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Mexico
- Oman
How they compare
Mexico currently reports 51.2% against 51.1% in Oman, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Mexico ahead.
Mexico ranks 129th and Oman ranks 130th of 185 countries.
Across the 3 decades both report, Mexico averaged higher in 2 and Oman in 1.
Head to head by decade
| Decade | Mexico | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.9% | 76.9% | 1.0% | Mexico |
| 2010s | 79.2% | 78.8% | 0.4% | Mexico |
| 2020s | 52.7% | 58.5% | 5.9% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Mexico or Oman?
- Mexico, at 51.2% against 51.1% in Oman as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Mexico and Oman?
- 0.1%, with Mexico ahead.
- How many years of comparable data are there for Mexico and Oman?
- 6 years are reported by both, from 2000 to 2021.
- How do Mexico and Oman rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Mexico ranks 129th and Oman ranks 130th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.